# Study of the Efficacy of ESTRATEST® H.S. Tablets in Relieving Menopausal Symptoms in Estrogenized Postmenopausal Women

> **NCT00141570** · PHASE2 · COMPLETED · sponsor: **Solvay Pharmaceuticals** · enrollment: 350 (—)

## Conditions studied

- Menopause

## Interventions

- **DRUG:** esterified estrogens 0.625 mg and methyltestosterone 1.25 mg

## Key facts

- **NCT ID:** NCT00141570
- **Lead sponsor:** Solvay Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-06
- **Primary completion:** 2007-06
- **Final completion:** 2007-06
- **Target enrollment:** 350 (—)
- **Last updated:** 2015-01-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00141570

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00141570, "Study of the Efficacy of ESTRATEST® H.S. Tablets in Relieving Menopausal Symptoms in Estrogenized Postmenopausal Women". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00141570. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*